Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

August 22, 2012

Primary Completion Date

January 14, 2020

Study Completion Date

January 14, 2020

Conditions
GliomaGlioblastoma
Interventions
RADIATION

FDOPA PET/CT

Positron emission tomography (PET) is an established imaging technique that utilizes small amounts of radioactivity attached to very minimal amounts of substances (tracers) that are injected via a hand or arm vein. These substances can track certain features of cancers that can be visualized by using the PET/CT scanner, in this instance the amino acid 18F-DOPA.

Trial Locations (1)

90095

UCLA, Los Angeles

All Listed Sponsors
collaborator

Kaiser Permanente

OTHER

collaborator

The Methodist Hospital Research Institute

OTHER

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT01813877 - Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma | Biotech Hunter | Biotech Hunter